TLRY

Tilray Brands, Inc.

Nasdaq · Medicinal Chemicals & Botanical Products · CIK 0001731348

$5.34 -1.20% $630.4M

5 New Institutional Positions

Vol

Market Cap$630.4M

Cap SizeSmall Cap

Analyst ConsensusHold (47%)

Inst. Holders5 funds

Inst. Value$10.5M

Inst. Activity5 buys / 0 sells

Insider Activity0B / 1S

Insider Net $-$232.9K

Reddit Sentiment40° Cool

SEC Reports3

Press Releases7

Exchange Nasdaq·Sector Medicinal Chemicals & Botanical Products·CIK 0001731348·Prev Close $5.41

Recent Activity

Apr 21, 2026 SEC

Tilray Brands reported Q3 fiscal 2026 results with net revenue of $206.7 million, up 11% year-over-year, driven by 73% g

8-K — Impact 6/10

Apr 21, 2026 Insider

Hopkinson David G. sold 33,556 shares

Director @ $6.94 ($232.9K)

Apr 15, 2026 SEC

Tilray Brands is conducting an at-the-market offering of up to $180 million in common stock through Jefferies, TD Securi

424B5 — Impact 6/10

Apr 15, 2026 SEC

Tilray Brands entered into an at-the-market (ATM) equity offering program to sell up to $180 million in common stock thr

8-K — Impact 4/10

Inst.

VANGUARD GROUP INC — NEW

436,921 shares ($3.9M)

Inst.

MORGAN STANLEY — NEW

284,764 shares ($2.6M)

May 13, 2026 short_volume

Short Volume: TLRY — 58.3% short (1.1M / 1.8M)

Short: 1,052,627 | Exempt: 3,703 | TRF Vol: 1,804,871 | Short Ratio: 58.3% | Off-exchange volume (da

Apr 15, 2026 Press

Tilray Brands announced the acquisition of UK-based medical cannabis clinic and pharmacy platform Lyphe Group, integrati

Impact 6/10

Price Targets

$10.04 +87.9% upside Strong Buy

Current $5.35 Low $6.50 Median $9.00 High $24.00 9 analysts

$6.50 $24.00

Analyst Ratings

Hold47% buy · 17 analysts

3Strong Buy

5Buy

9Hold

0Sell

0Strong Sell

Recent Analyst Actions

Date	Firm	Action	Rating
Apr 2, 2026	Roth Capital	UPGRADE	Neutral → Buy
Mar 30, 2026	TD Cowen	MAINTAIN	Buy → Buy
Jan 20, 2026	Roth Capital	MAINTAIN	Neutral → Neutral

Earnings Estimates

Period	EPS Est.	Range	Growth	#
Current Q	$0.27 ▲ +8.0%	$0.27 — $0.27	35% YoY	1
Next Q	$-0.13	$-0.21 — $-0.04	0% YoY	4
Current FY	$-0.08 ▼ -620.5%	$-0.48 — $0.32	-179% YoY	2
Next FY	$-0.33 ▼ -375.5%	$-0.81 — $-0.05	46% YoY	7

Latest Reports

MIXED 8-K 6/10

Tilray Brands reported Q3 fiscal 2026 results with net revenue of $206.7 million, up 11% year-over-year, driven by 73% g

Apr 21, 2026

BEARISH 424B5 6/10

Tilray Brands is conducting an at-the-market offering of up to $180 million in common stock through Jefferies, TD Securi

Apr 15, 2026

MIXED Press 6/10

Tilray Brands announced the acquisition of UK-based medical cannabis clinic and pharmacy platform Lyphe Group, integrati

Apr 15, 2026

Top Institutional Holders

Fund	Value	Move
VANGUARD GROUP INC	$3.9M	NEW
MORGAN STANLEY	$2.6M	NEW
TWO SIGMA INVESTMENTS, LP	$1.7M	NEW
BANK OF AMERICA CORP	$1.6M	NEW
WELLS FARGO & COMPANY/MN	$633.8K	NEW

Recent Insider Trades

Date	Insider	Type	Value
Apr 21, 2026	Hopkinson David	SELL	$232.9K

Reddit Sentiment

40°

Cool

Bearish Neutral Bullish

1 mentions 0 bullish 1 bearish

5 institutional holders with $10.5M total value (1,159,764 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, TWO. Net buying activity: 5 institutions added/increased vs 0 reduced.

Top Institutional Holders — 2025-Q4

#	Fund	Shares	Value	% of Tracked	Last Move
1	VANGUARD GROUP INC	436,921	$3.9M	37.7%	NEW
2	MORGAN STANLEY	284,764	$2.6M	24.6%	NEW
3	TWO SIGMA INVESTMENTS, LP	186,646	$1.7M	16.1%	NEW
4	BANK OF AMERICA CORP /DE/	181,246	$1.6M	15.6%	NEW
5	WELLS FARGO & COMPANY/MN	70,187	$633.8K	6.1%	NEW

Recent Position Changes

Fund	Action	Prev Shares	Curr Shares	Change %	Value	Quarter
VANGUARD GROUP INC	NEW	—	436,921	—	$3.9M	2025-Q4
MORGAN STANLEY	NEW	—	284,764	—	$2.6M	2025-Q4
TWO SIGMA INVESTMENTS, LP	NEW	—	186,646	—	$1.7M	2025-Q4
BANK OF AMERICA CORP /DE/	NEW	—	181,246	—	$1.6M	2025-Q4
WELLS FARGO & COMPANY/MN	NEW	—	70,187	—	$633.8K	2025-Q4

1 unique insiders with 1 transactions. Net insider value: -$232.9K ($0.00 bought, $232.9K sold).

Insider Transactions

Date	Insider	Title	Type	Shares	Price	Value
Apr 21, 2026	Hopkinson David G.	Director	SELL	33,556	$6.94	$232.9K

3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 1 mixed, 1 neutral. Avg impact: 5.3/10.

MIXED 8-K 6/10

Tilray Brands reported Q3 fiscal 2026 results with net revenue of $206.7 million, up 11% year-over-y

Apr 21, 2026

BEARISH 424B5 6/10

Tilray Brands is conducting an at-the-market offering of up to $180 million in common stock through

Apr 15, 2026

NEUTRAL 8-K 4/10

Tilray Brands entered into an at-the-market (ATM) equity offering program to sell up to $180 million

Apr 15, 2026

MIXED 6/10

Tilray Brands announced the acquisition of UK-based medical cannabis clinic and pharmacy platform Ly

Apr 15, 2026

BULLISH 7/10

Tilray Brands reported its third fiscal quarter results with 11% year-over-year revenue growth to a

Apr 1, 2026

NEUTRAL 4/10

Tilray Brands has partnered with The Magnum Ice Cream Company to launch a new line of ready-to-drink

Mar 26, 2026

NEUTRAL 3/10

Tilray Brands announced it will release its Q3 fiscal 2026 earnings on April 1, 2026, before market

Mar 25, 2026

BULLISH 7/10

Tilray Brands announced the acquisition of key U.S. assets from BrewDog, including its Ohio brewery,

Mar 16, 2026

BULLISH 7/10

Tilray Brands' pharmaceutical division has formed a strategic partnership with CC Pharma, 14U Pharma

Mar 12, 2026

BULLISH 8/10

Tilray Brands completed the acquisition of key BrewDog assets, including its global brand, UK brewin

Mar 2, 2026

Current analyst consensus: Hold (47% buy). Based on 17 analysts: 3 strong buy, 5 buy, 9 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$10.04 mean target +87.9% upside Strong Buy (3.00)

$6.50 Low $24.00 High

Metric	Value
Current Price	$5.35
Target Low	$6.50
Target Mean	$10.04
Target Median	$9.00
Target High	$24.00
# Analysts	9
Recommendation	Strong Buy (3.00)

Earnings Estimates & Revisions

Period	EPS Avg	EPS Low	EPS High	EPS Growth	30d Rev.	Up/Down	Rev. Avg	Rev. Growth	Analysts
Current Q 2026-05-31	$0.27	$0.27	$0.27	35.0%	+8.0%	1↑ 0↓	$0.3B	11.6%	1
Next Q 2026-08-31	$-0.13	$-0.21	$-0.04	0.0%	—	0↑ 1↓	$0.3B	22.6%	4
Current FY 2026-05-31	$-0.08	$-0.48	$0.32	-179.1%	-620.5%	0↑ 1↓	$0.9B	7.7%	2
Next FY 2027-05-31	$-0.33	$-0.81	$-0.05	46.3%	-375.5%	0↑ 3↓	$1.1B	24.6%	7

Current Quarter EPS Revision History

Timepoint	EPS Estimate	Change
Current	$0.270
7d ago	$0.250	+0.020
30d ago	$0.250	+0.020
60d ago	$0.250	+0.020
90d ago	$0.300	-0.030

2 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.

Individual Analyst Actions

Date	Analyst Firm	Action	Previous Rating	New Rating
Apr 2, 2026	Roth Capital	UPGRADE	Neutral	Buy
Mar 30, 2026	TD Cowen	MAINTAIN	Buy	Buy
Jan 20, 2026	Roth Capital	MAINTAIN	Neutral	Neutral

Monthly Consensus History

Period	Strong Buy	Buy	Hold	Sell	Buy %
May 1, 2026	3	5	9	0	47%
Apr 1, 2026	3	4	10	0	41%
Mar 1, 2026	3	4	9	1	41%
Feb 1, 2026	3	4	9	1	41%
Jan 1, 2026	3	4	8	1	44%

Strong BuyBuyHoldSellStrong Sell

∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

40°

Cool

Bearish Neutral Bullish

1 mentions 0 bullish 1 bearish 1 time period

Reddit Sentiment History

Date	Mentions	Sentiment	Bullish	Bearish	Threads
Apr 24, 2026	1	40° Cool	0	1	1

Recent Reddit Threads

r/wallstreetbets Bearish 26d 19h ago

INTC Last Minute Play

▲ 1 💬 1 ⚡ 0.5

May 13, 2026

short_volume

Short Volume: TLRY — 58.3% short (1.1M / 1.8M)

Short: 1,052,627 | Exempt: 3,703 | TRF Vol: 1,804,871 | Short Ratio: 58.3% | Off-exchange volume (dark pool + OTC)

May 4, 2026

other

10 Barrel Brewing Launches Clean Slate and Salty Sips, Expanding RTD Line with Functional N/A and Low-Sugar Cocktails

First-of-its-kind Functional Non-Alcoholic Cocktail Meets Crushable, Low-Sugar Vodka Refresher - Both Crafted with Real Fruit Juice and a Pinch of Ore

Apr 30, 2026

contract

SweetWater Brewing Company and Salt Life Launch Livin’ Salty: The Ultimate Summer Craft Brew Collaboration

Introducing Livin’ Salty: Your Go-To Lager for Sun, Sand, and Summer Fun <pre>Introducing Livin’ Salty: Your Go-To Lager for Sun, Sand, and Summer Fun

Apr 28, 2026

short_interest

FTD: TLRY — 95,902 shares ($0.7M) failed to deliver

Settlement: 20260428, Price: $6.89, FTD Value: $660,764.78, TILRAY BRANDS INC COM NEW (DE)

Apr 27, 2026

short_interest

FTD: TLRY — 90,481 shares ($0.6M) failed to deliver

Settlement: 20260427, Price: $6.75, FTD Value: $610,746.75, TILRAY BRANDS INC COM NEW (DE)

Apr 24, 2026

short_interest

FTD: TLRY — 681,175 shares ($4.7M) failed to deliver

Settlement: 20260424, Price: $6.94, FTD Value: $4,727,354.5, TILRAY BRANDS INC COM NEW (DE)

Apr 23, 2026

other

Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling

Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients <pre>Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access fo

Apr 23, 2026

short_volume

Short Volume: TLRY — 55.3% short (11.5M / 20.8M)

Short: 11,509,613 | Exempt: 246,502 | TRF Vol: 20,817,560 | Short Ratio: 55.3% | Off-exchange volume (dark pool + OTC)

Apr 23, 2026

short_interest

FTD: TLRY — 639,037 shares ($5.0M) failed to deliver

Settlement: 20260423, Price: $7.87, FTD Value: $5,029,221.19, TILRAY BRANDS INC COM NEW (DE)

Apr 21, 2026

short_interest

FTD: TLRY — 78,500 shares ($0.6M) failed to deliver

Settlement: 20260421, Price: $7.15, FTD Value: $561,275, TILRAY BRANDS INC COM NEW (DE)

Apr 20, 2026

other

Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care

<p align="left">NEW YORK and LEAMINGTON, Ontario, April 20, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=UvnPgwyGub3

Apr 15, 2026

m_and_a

Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership

Tilray Advances UK Healthcare Platform with Lyphe Acquisition, Positions BrewDog for Strong Growth, and Prepares for U.S. Rescheduling and Medical Can

Apr 8, 2026

other

Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced Consumer

<p>TORONTO, April 08, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=9Fa8fc9FdT2Ej0ofBUZOrs6IK8Nakh1u7JxolIYEdEzEqulOq

Apr 7, 2026

other

Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts

First Released in 2025 as the limited-edition Broncos Whiskey, Breckenridge Honey Whiskey Delivers Distinctive Character and Exceptional Flavor <pre>F

Apr 7, 2026

short_interest

FTD: TLRY — 118,626 shares ($0.8M) failed to deliver

Settlement: 20260407, Price: $6.66, FTD Value: $790,049.16, TILRAY BRANDS INC COM NEW (DE)